Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.

Autor: Naina, H. V.1, Pruthi, R. K.1, Inwards, D. J.1, Dingli, D.1, Litzow, M. R.1, Ansell, S. M.1, William, H. J.1, Dispenzieri, A.1, Buadi, F. K.1, Elliott, M. A.1, Gastineau, D. A.1, Gertz, M. A.1, Hayman, S. R.1, Johnston, P. B.1, Lacy, M. Q.1, Micallef, I. N.1, Porrata, L. F.1, Kumar, S.1 kumar.shaji@mayo.edu
Zdroj: Bone Marrow Transplantation. Feb2011, Vol. 46 Issue 2, p291-293. 3p. 1 Chart.
Databáze: Academic Search Ultimate